Neoplasia/BPH

	Application of three-dimensional Superb micro-vascular imaging (3D-SMI) combined with quantitative blood flow analysis in the noninvasive diagnosis of renal tumors. Ultrasound J Mao Y, Yu C, Wang T, Li F, Hou W, Wei X, Mu J. PMID: 41324744 [PubMed]
	A Computational Pathology Model to Predict Docetaxel Benefit in Localized High-Risk and Metastatic Prostate Cancer. Clin Cancer Res Medina S, Tokuyama N, Hammouda K, Pathak T, Mirtti T, Fu P, Gupta S, Lal P, Sandler HM, Correa R, Chafe S, Shah A, Efstathiou JA, Hoffman K, Straza M, Hallman MA, Jordan R, Pugh SL, Sweeney CJ, Madabhushi A. PMID: 41324555 [PubMed - as supplied by publisher]
	Automated imaging as an adjunct to serum and clinical biomarkers: a new validated prediction tool for metastatic castration-resistant prostate cancer. Clin Cancer Res Morris MJ, Flynn J, Zhao B, Anand A, Sjöstrand K, Larson SM, Regazzi AM, Borzillo GV, Park A, Schwartz LH, Heller G. PMID: 41324553 [PubMed - as supplied by publisher]
	A randomized controlled phase III trial on continued or paused PD-1 pathway blockade for patients with advanced renal cell carcinoma (JCOG1905, STOP study): a study protocol. Jpn J Clin Oncol Matsumoto T, Tanegashima T, Takeuchi A, Sasaki K, Ogawa G, Kojima T, Kawahara T, Matsui Y, Nishiyama N, Nishiyama H, Kitamura H, Eto M. PMID: 41324490 [PubMed - as supplied by publisher]
	Drug repositioning of regorafenib for renal cell carcinoma identifies DDR2â€‘associated sensitivity in ACHN models. Korean J Physiol Pharmacol Moon J, Vo VTA, Nhat LT, Eom M, Jeong Y. PMID: 41324163 [PubMed - as supplied by publisher]
	Diagnostic accuracy of the Vesical Imaging Reporting and Data System for muscle-invasive bladder cancer and its role in reducing repeat transurethral resection of bladder tumor: A systematic review. Bladder (San Franc) Nandi D, Kumar SK, Hasan A, Kumar V. PMID: 41324075 [PubMed]
	(18)F-fluorodeoxyglucose positron emission tomography combined with computed tomography for bladder cancer staging: Diagnostic accuracy and prognostic implications. Bladder (San Franc) Huynh TNA, Wei X, Arulshankar S, Lam D, Lim KY, Huang J, Rajarubendra N, Chu K, Donnellan S, Ranasinghe W. PMID: 41324069 [PubMed]
	Real-world management of T1 high-grade bladder cancer: A 14-year retrospective single-center study. Bladder (San Franc) Lv Z, Feng Y, Guo B, Jiang B, Zhang H, Lu Y, Gao W, Tang J, Ai Q, Cheng Q, Li H. PMID: 41324068 [PubMed]
	A non-invasive MRI-based multimodal fusion deep learning model (MF-DLM) for predicting overall survival in bladder cancer: a multicentre retrospective study. EClinicalMedicine Cai L, Bai R, Cao Q, Sun W, Wang F, Liu X, Liang B, Jiang M, Wang G, Shao Q, Jiang X, Wang C, Chen C, Tan Z, Wu Q, Bao M, Yu H, Li P, Yang X, Lu Q. PMID: 41324013 [PubMed]
	A head-to-head comparison of sextant-systematic biopsy vs. extended-systematic biopsy for prostate cancer diagnosis in the era of MRI-targeted biopsy: SEXTANT-PRO non-inferiority randomized clinical trial. EClinicalMedicine Deng R, Shang J, Wu J, Tian S, Li D, Shen Q, Hu S, Shang M, Qiu J, Zhou J, Cai L, Gong K, Liu Y. PMID: 41324010 [PubMed]
	A case-based review of urachal carcinoma with mixed small cell neuroendocrine and adenocarcinoma components, with one new case report and analysis of nine published cases. Front Endocrinol (Lausanne) Chu J, Zhai J, Ma Q, Zhang Z, Yuan Y, Yuan H, Wei C, Wang M. PMID: 41323974 [PubMed - indexed for MEDLINE]
	Editorial: New potential biomarkers and cellular strategies for the study of prostate cancer and testicular cancer cells. Front Endocrinol (Lausanne) Bossio S, Recchia AG, Ramírez De Arellano Sánchez JA. PMID: 41323969 [PubMed - in process]
	Unravelling targeted therapy in prostate cancer: from molecular mechanisms to translational opportunities. Front Cell Dev Biol Wu L, Qiu J, Hong Z, Wang Q, Li Q, Zhou W. PMID: 41323732 [PubMed]
	Comparison of cone beam computed tomography post-processing methods for online adaptive proton therapy of prostate cancer. Phys Imaging Radiat Oncol Bobi, Bushe DH, Lee H, Winey BA, Efstathiou JA, Paganetti H, Pursley J, Peters N, Nenoff L. PMID: 41323215 [PubMed]
	Diagnostic challenges in bleeding renal tumors: A ruptured papillary renal cell carcinoma showing regression followed by progression. Radiol Case Rep Yoshida R, Komatsubara Y, Yoshizako T, Mitani K, Ogawa K, Wada K, Araki A, Kaji Y. PMID: 41323187 [PubMed]
	The Future of Bladder Cancer Therapies: Integrating Hydrogel Scaffolds for Epigenetic Regulator Delivery. Cureus John KA, Odibo AO, Soliman AM, Abayomi M, Awah FM, Barrah VU. PMID: 41322853 [PubMed]
	Synthetic CT generation from CBCT using deep learning for adaptive radiotherapy in prostate cancer. Front Radiol Ça, Erta, Cebe MS, Kara I, Kheradmand N, Metcalfe E. PMID: 41322652 [PubMed]
	Prostate cancer diagnostics: the independent and combined roles of SelectMDx and mpMRI. Cent European J Urol C, Nechita OC, B, Toma CV, Ra, Petca RC, Aurelian J, Constantin T, Jinga V. PMID: 41322456 [PubMed]
	Late relapse of testicular germ cell tumor: An individual patient data meta-analysis of disease characteristics, treatments, and oncological outcomes. Cent European J Urol Parizi MK, Singla N, Daneshmand S, Heidenreich A, Bagrodia A, Margulis V, Matsukawa A, Tsuboi I, Shariat SF. PMID: 41322452 [PubMed]
	In vivo endoscopic cryobiopsy of urothelial tumors in the upper urinary tract and bladder: A feasibility pilot study in humans. Cent European J Urol , Nowak , Tomczak W, Chorbi, Kaczorowski M, Ha, Szyde, Krajewski W. PMID: 41322445 [PubMed]

Articles 1 - 20 / 183554

Page 1 of 9178



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy